NEW YORK (GenomeWeb News) – DASA Group and Natera have reached a deal to offer Natera's non-invasive prenatal diagnostic test in Brazil, the companies announced on Thursday.
Financial and other terms were not disclosed.
NEW YORK (GenomeWeb News) – Sequenom today said that its San Diego lab, the Sequenom Center for Molecular Medicine, has received a clinical laboratory permit from New York Department of Health's Wadsworth Center Clinical Laboratory Evaluation Program.
NEW YORK (GenomeWeb News) – Illumina announced late Thursday that Verinata Health has received a clinical laboratory permit from the State of New York for its laboratory, allowing the company to market its Verifi non-invasive prenatal diagnostic test in the state.
NEW YORK (GenomeWeb News) – Sequenom and CombiMatrix today announced an agreement to market chromosomal microarray analysis testing services "to broaden and confirm the results of non-invasive prenatal testing" to doctors and patients.
NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market on Wednesday that its revenues in the second quarter jumped 91 percent year over year, but missed the consensus Wall Street estimate as changes in molecular diagnostic billing and payment codes delayed receipt of payments
NEW YORK (GenomeWeb News) – BGI subsidiary BGI Health and the Association of Czech genetic centers announced on Wednesday the founding of the companies' first test center focused on prenatal diagnostics in Europe.
NEW YORK (GenomeWeb News) – Illumina said today that its noninvasive prenatal testing subsidiary Verinata Health has signed an exclusive agreement with Teva Pharmaceutical Industries to commercialize its Verifi test in Israel.
NEW YORK (GenomeWeb News) – Natera and Unilabs have struck an agreement under which Unilabs will distribute Natera's non-invasive prenatal screening test, Panorama, in Switzerland and Scandinavia, the companies said today.